Rapport Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: RAPP · Form: 8-K · Filed: Jun 18, 2025 · CIK: 2012593
| Field | Detail |
|---|---|
| Company | Rapport Therapeutics, Inc. (RAPP) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
TL;DR
Rapport Therapeutics filed an 8-K for shareholder vote matters on June 17th.
AI Summary
Rapport Therapeutics, Inc. filed an 8-K on June 18, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 17, 2025. The filing details corporate actions and governance matters for the company, incorporated in Delaware with its principal executive offices in Boston, Massachusetts.
Why It Matters
This filing indicates important corporate governance actions are being taken by Rapport Therapeutics, which could impact shareholder rights and company direction.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure regarding a vote of security holders and does not appear to contain material adverse information.
Key Numbers
- 001-42121 — SEC File Number (Identifies the company's filing with the SEC.)
- 88-0724208 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Rapport Therapeutics, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- Boston, Massachusetts (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Rapport Therapeutics' security holders on June 17, 2025?
The filing states that the purpose of the report is to disclose 'Submission of Matters to a Vote of Security Holders' on June 17, 2025, but the specific details of these matters are not provided in the excerpt.
When was Rapport Therapeutics, Inc. incorporated?
Rapport Therapeutics, Inc. was incorporated in Delaware, as indicated by the filing.
What is the address of Rapport Therapeutics' principal executive offices?
The principal executive offices of Rapport Therapeutics, Inc. are located at 99 High Street, Suite 2100, Boston, Massachusetts 02110.
What is the SEC file number for Rapport Therapeutics, Inc.?
The SEC file number for Rapport Therapeutics, Inc. is 001-42121.
What is the standard industrial classification for Rapport Therapeutics, Inc.?
Rapport Therapeutics, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Rapport Therapeutics, Inc. (RAPP).